Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Mesoblast Limited ( (AU:MSB) ) has provided an update.
Mesoblast Limited has announced that JPMorgan Chase & Co. and its affiliates have become substantial holders in the company, holding a 5.06% voting power with 64,614,620 ordinary shares. This development indicates a significant investment by JPMorgan, which could influence Mesoblast’s market dynamics and stakeholder interests, highlighting the strategic importance of this financial backing in the company’s future operations.
The most recent analyst rating on (AU:MSB) stock is a Buy with a A$1.10 price target. To see the full list of analyst forecasts on Mesoblast Limited stock, see the AU:MSB Stock Forecast page.
More about Mesoblast Limited
YTD Price Performance: -42.10%
Average Trading Volume: 6,082,418
Technical Sentiment Signal: Buy
Current Market Cap: A$2.29B
For an in-depth examination of MSB stock, go to TipRanks’ Overview page.